Bibliographic Details
| Title: |
Neonatal treatment with fluoxetine alters locomotor activity and the cortical glial/neuron index in rats with cerebral palsy. |
| Authors: |
de Albuquerque, Glayciele Leandro, Manhães-de-Castro, Raul, Lacerda, Diego Cabral, Calado, Caio Matheus Santos da Silva, Bezerra de Morais, André Teracio, Visco, Diego Bulcão, Manhães-de-Castro, Francisco Machado, Toscano, Ana Elisa aeltoscano@yahoo.com.br |
| Source: |
Canadian Journal of Physiology & Pharmacology. Jul2023, Vol. 101 Issue 7, p327-339. 13p. 1 Color Photograph, 2 Charts, 6 Graphs. |
| Subject Terms: |
*CEREBRAL palsy, *FLUOXETINE, *SEROTONIN uptake inhibitors, *SOMATOSENSORY cortex, *MOVEMENT disorders, *NEURONS |
| Abstract: |
Cerebral palsy (CP) is characterized by motor disorders, including deficits in locomotor activity, coordination, and balance. Selective serotonin reuptake inhibitors have been shown to play an important role in brain plasticity. This study investigates the effect of neonatal treatment using fluoxetine on locomotor activity and histomorphometric parameters of the primary somatosensory cortex (S1) in rats submitted to an experimental model of CP. CP was found to reduce bodyweight and locomotion parameters and also to increase the glia/neuron index in the S1. Administration of fluoxetine 10 mg/kg reduced bodyweight, impaired locomotor activity parameters, and increased the number of glial cells and the glia/neuron ratio in the S1 in rats with CP. However, treatment with fluoxetine 5 mg/kg was not found to be associated with adverse effects on locomotor activity and seems to improve histomorphometric parameters by way of minor changes in the S1 in animals with CP. These results thus indicate that experimental CP, in combination with the use of a high dose of fluoxetine (10 mg/kg), impairs locomotor and histomorphometric parameters in the S1, while treatment with a low dose of fluoxetine (5 mg/kg) averts the negative outcomes associated with a high dose of fluoxetine in relation to these parameters but produces no protective effect. [ABSTRACT FROM AUTHOR] |
|
Copyright of Canadian Journal of Physiology & Pharmacology is the property of Canadian Science Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
